INTRODUCTION
============

Basal cell nevus syndrome (BCNS), also known as Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS), is an uncommon disorder, which is inherited as an autosomal dominant trait[@B1]. Patients with this syndrome often have anomalies of multiple organs, such as abnormalities of the skin, skeleton, and nervous system. This disorder is characterized by variable clinical manifestations, including multiple Basal cell carcinomas (BCCs); odontogenic keratocysts of the jaw or a polyostotic bone cyst; pitted depression on the palms and soles; skeletal anomalies, including bifid, fused rib or vertebrae, and scoliosis; congenital malformation, including cleft lip or palate, microphthalmos, and polydactyly; central nervous system abnormalities, including lamellar or early calcification of the falx cerebri, and medulloblastoma in childhood[@B2],[@B3]. Germline mutations in the PTCH gene on chromosome 9q23 have been found in 35\~50% of patients. The PTCH gene is known to be important in developmental abnormalities, segmentation, and growth regulation. A deletion or inactivation of this gene is believed to cause the disorder because the PTCH gene plays a role as a tumor suppressor gene[@B4],[@B5]. BCCs have various clinical and histologic subtypes, which include nodular or solid, cystic, micronodular, pigmented, adenoid, superficial, morpheaform or sclerosing, fibroepithelioma of Pinkus, and mixed type. Approximately one third of patients with this syndrome show various types of BCCs[@B6]-[@B8].

However, only one case of BCNS with diverse histologic findings of BCCs has been reported in Korea[@B9]. Herein, we report on an interesting case of BCNS in a 68-year-old male who presented with several histologic types of BCCs.

CASE REPORT
===========

A 68-year-old man presented with multiple pigmented papulo-nodular lesions on the face, back, and thigh for several years. He had no subjective symptoms and no other medical history, and there were no other affected relatives having BCNS. Physical examination revealed a pea-sized, pigmented nodule on the right nasolabial fold ([Fig. 1A](#F1){ref-type="fig"}), with erythematous, hyperpigmented patches, multiple-sized pigmented nevi on his back ([Fig. 1B, C](#F1){ref-type="fig"}), and a black colored and ulcerative plaque on the right thigh ([Fig. 1D](#F1){ref-type="fig"}). He had multiple pits on his palms ([Fig. 2A](#F2){ref-type="fig"}) and mild ocular hypertelorism. Skull X-ray showed intracranial calcification of the falx cerebri ([Fig. 2B](#F2){ref-type="fig"}), and a cystic lesion of the left maxillary sinus revealed was by facial CT ([Fig. 2C](#F2){ref-type="fig"}). It was proven to be an odontogenic keratocyst by histologic finding.

Histopathological examination revealed several histological variants of BCCs; nasolabial fold (nodular, [Fig. 3A](#F3){ref-type="fig"}), back (superficial, [Fig. 3B](#F3){ref-type="fig"}), and thigh (mixed pattern of nodular, superficial, and pigmented type, [Fig. 3C](#F3){ref-type="fig"}). Multiple BCCs in the skin and the odontogenic cyst were treated with surgical excision, and no further relapse was observed.

DISCUSSION
==========

BCNS, or Gorlin syndrome, was first described by Jarisch and White in 1894[@B10],[@B11] and was later established as a syndrome by Gorlin and Goltz in 1960[@B12]. This disease was initially characterized by the presence of triads of multiple basal cell carcinomas, odontogenic keratocysts of the jaw, and skeletal anomalies, including bifid rib and scoliosis[@B12]. Supplementary clinical manifestations of intracranial ectopic calcification and palmar or plantar pits were also observed, and these symptoms were added to the major criteria for diagnosis[@B13].

While it is known to be a familial and an autosomal dominant syndrome, the exact pathogenesis is not understood. The syndrome exhibits high penetrance and variable expressivity[@B1]. The genetic abnormality underlying BCNS is caused by mutations in the PTCH gene and by downregulation of the sonic hedgehog signaling pathway. The PTCH gene acts as a tumor suppressor gene, and has been mapped to the long arm of chromosome 9 q22.3-q31. Loss of function of the gene induces abnormal growth and development of normal tissues, which leads to the syndrome[@B4],[@B5].

Diagnosis of BCNS can be made when two of the five major criteria, or one major and two minor criteria are present[@B14],[@B15]. Major criteria of this syndrome include the following: (1) multiple (two or more) basal cell carcinomas or one BCC under 30 years, or ten or more basal cell nevi; (2) odontogenic keratocysts of the jaw; (3) multiple (three or more) palmar or plantar pits; (4) ectopic calcification, such as lamellar calcification of the falx cerebri; and (5) family history of Gorlin\'s syndrome. Minor manifestations include the following: (1) skeletal anomalies, such as bifid, fused rib or vertebrae, marked syndactyly of the digits, and scoliosis; (2) congenital malformation, including cleft lip or palate, macrocephaly, hypertelorism, and frontal bossing; (3) medulloblastoma in young children; and (4) cardiac or ovarian fibroma. In addition, Lo Muzio et al.[@B1] suggested a specific clinical protocol for examination of patients with suspicion of this syndrome. Cases of BCNS in advanced age have occasionally been reported. However, since lesions were treated at any point where symptoms not compatible with BCNS criteria were observed, those cases did not actually occur in old age. Most patients showed multiple basal cell carcinomas, which were regarded as seborrheic keratosis, pigmented nevus, and melanocytic nevus. In addition, the odontogenic cyst, palmoplantar pits, and other clinical findings were treated when symptoms developed; therefore, it is difficult to demonstrate that BCNS occurs in older patients.

BCCs in this syndrome have been found in 50 to 75% of patients and they most often appear between puberty and 35 years of age. The number of lesions varies from a few to several thousand and ranges in size from 1 to 30 mm in diameter[@B3],[@B5],[@B16]. Pits of palms and soles are distinct features of this syndrome and these lesions are 2\~3 mm in diameter and 1\~3 mm in depth[@B9]. They may occur in 85% of patients with BCNS who are over the age of 20 years. Histologically, loss of the horny layer, thin granular layer, vacuolization of the malphigian layer, and irregular elongation of the epidermal rete ridge are observed[@B17].

The histopathology of BCCs in this syndrome cannot be differentiated from that of sporadic BCCs[@B3],[@B7]. In addition, approximately 30% of patients have two or more histologic sub-types of BCCs with patterns of superficial, solid or nodular, cystic, adenoid, morpheaform or sclerosing, and fibroepithelioma of Pinkus[@B6]-[@B8]. Several cases of BCNS have been reported in Korea[@B5],[@B9],[@B16]-[@B18]; however, only one reported case has shown various histopathologic types of BCCs in the syndrome[@B9]. According to this report, two cases of BCNS presented with superficial, nodular, and follicular or infundibulocystic patterns in histologic types of BCCs.

BCNS must be distinguished from rare disorders, such as linear unilateral nevoid BCCs with comedones, Bazex syndrome, and Rombo syndrome[@B17]. Bazex syndrome is an X-linked dominant syndrome, characterized by multiple BCCs of the face, hypohidrosis, hypotrichosis, and follicular atroderma of the extremities. Rombo syndrome is a dominantly inherited disorder with multiple BCCs, hypotrichosis, vermiculate atrophoderma, milia, trichoepitheliomas, and peripheral cyanosis[@B19].

Early diagnosis and proper management of this syndrome are important, since it has malignant transformation. Management of patients with BCNS involves genetic counseling, imaging studies, biopsy of suspected skin lesions, and treatment of related findings[@B1]. Surgical treatments, including cryotherapy, electrodessication and curettage, simple excision, and Mohs micrographic surgery are used for most lesions. Topical therapy with retinoid cream, imiquimod cream, and 5-flourouracil cream may be used in treatment of superficial and multiple BCCs lesions[@B2]. Treatment with oral retinoid may suppress the new BCCs lesions and result in reduction of symptoms. Recently, another therapeutic option is photodynamic therapy, involving use of photosensitizing agents that have preferentially specific effects on malignant cells[@B3].

In conclusion, we can diagnose BCNS clinically according to 4 major criteria, which include the following: (1) discrete pigmented BCCs lesions on the face, back, and thigh proven by histology, showing several patterns, including nodular, superficial, and pigmented types of BCCs; (2) multiple palmar pits; (3) odontogenic keratocyst of the left maxillary sinus and (4) calcified falx cerebri. Since only one case of BCNS associated with various histologic patterns of BCCs has been reported in Korea, we hereby report on an interesting case of BCNS showing several histologic types of BCCs.

![Nodular pigmented lesion with a rolled border on the right nasolabial fold (A). Multiple, various-sized pigmented lesions on the upper back, some of which are flat, erythematous, well-circumscribed, hyperpigmented patches (B, C). Dark colored and ulcerative plaque on the right thigh (D)](ad-23-S36-g001){#F1}

![Multiple pits on the palm (A). Skull X-ray shows ectopic calcification in the falx cerebri (B) and facial CT shows a well-defined round cystic mass in the left maxillary sinus with peripheral thin wall calcification (C).](ad-23-S36-g002){#F2}

![Histologic findings. Nodular type (nasolabial fold); a number of round or oval tumor islands and stromal retraction within the upper to mid dermis (A). Superficial type (back); multiple buds of basophilic cells extending into the papillary dermis from the basal layer of the epidermis (B). Mixed pattern (thigh); features of superficial, nodular, and some pigmented types (C) (H&E, ×100).](ad-23-S36-g003){#F3}
